Turner K, Edgar D, Hair M, Uttley L, Sternland R, Hunt L, Gokal R
Renal Unit, Manchester Royal Infirmary, UK.
Adv Perit Dial. 1992;8:265-8.
This study was undertaken to ascertain the effectiveness of an immobilization device in reducing exit site infections (ESI) in CAPD patients, and whether immuno-suppressive therapy, diabetes, disconnect system and Staphylococcus aureus nasal carriage had any bearing on the incidence of ESI. Sixty-six patients having a Tenckhoff catheter placement were randomly allocated into one of three groups; immobilizer, tape and non-immobilized group. The groups were monitored for the incidence of ESI over a total period of 347 patient months. The results show no significant difference in infection rates between the three groups, nor do the factors mentioned have any bearing on ESI rate. Whilst immobilization is important, the ineffectiveness of this device was probably related to its design problem.
本研究旨在确定一种固定装置在降低持续性非卧床腹膜透析(CAPD)患者出口处感染(ESI)方面的有效性,以及免疫抑制治疗、糖尿病、断开系统和金黄色葡萄球菌鼻腔携带情况是否与ESI的发生率有关。66例接受Tenckhoff导管置入的患者被随机分为三组之一:固定器组、胶带组和非固定组。对这些组在总共347个患者月的时间内进行ESI发生率监测。结果显示,三组之间的感染率无显著差异,上述因素也与ESI发生率无关。虽然固定很重要,但该装置的无效可能与其设计问题有关。